|
| 1. | 1. Lithium APA Practice Guidelines > TREATING BIPOLAR DISORDER: A Quick Reference Guide > C. Additional Information About Pharmacotherapeutic Agents |
|
| 2. | 1. Somatic Therapies APA Practice Guidelines > ASSESSING AND TREATING SUICIDAL BEHAVIORS: A Quick Reference Guide > C. Specific Treatment Modalities |
|
| 3. | 1. Lithium APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > D. Maintenance Treatment |
|
| 4. | 1. Lithium APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > F. Somatic Therapies for Children and Adolescents |
|
| 5. | 1. Lithium APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes |
|
| 6. | 1. Lithium APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > B. Somatic Treatments of Acute Depressive Episodes |
|
| 7. | 2. Lithium APA Practice Guidelines > Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors > Part A: Assessment, Treatment, and Risk Management Recommendations > IV. Specific Treatment Modalities > A. Somatic Therapies |
|
| 8. | a) Side effects APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 1. Lithium |
|
| 9. | b) Lithium APA Practice Guidelines > Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > D. Somatic Therapies > 1. Pharmacotherapy |
|
| 10. | b) Toxicity/overdose APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 1. Lithium |
|
| 11. | c) Implementation and dosing APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 1. Lithium |
|
| 12. | e) Lithium APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Substance Use Disorders, Second Edition > PART A. Treatment Recommendations for Patients With Substance Use Disorders > IV. Treatment of Alcohol-Related Disorders > C. Somatic Treatments > 3. Medications to treat alcohol abuse and dependence |
|
| 13. | e. Lithium APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder > Part B. Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Medications > 6. Other Agents |
|
| 14. | h) Lithium APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 2. Adjunctive medications |
|
| 15. | Implementation APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 2. Adjunctive medications > h) Lithium |
|
| 16. | Lithium is another medication commonly used as an adjunct; other agents in use are thyroid... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Acute Phase Somatic Treatments > 2. Failure to respond to pharmacotherapy in the acute phase > c) Augmenting antidepressant medications with other treatments |
|
| 17. | Lithium is usually started in low, divided doses to minimize side effects (e.g., 300 mg t.i.d.... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 1. Lithium > c) Implementation and dosing |
|
| 18. | Side effects APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 2. Adjunctive medications > h) Lithium |
|
| 19. | TABLE 397. Commonly used mood stabilizers in pregnancy: summary points Textbook of Psychiatry > Chapter 39. Treatment of Women > Psychiatric Disorders in Pregnancy > Treatment of Bipolar Disorder During Pregnancy |
|
| 20. | Additional augmentation strategies include the use of lithium (De Montigny et al. 1981; Dinan... Textbook of Psychiatry > Chapter 26. Psychopharmacology > Antidepressant Medications > Treatment of Specific Disorders > Treatment-Resistant Depression |
|